NIH halts clinical trial of hydroxychloroquine after finding no benefit to coronavirus patients

The National Institutes of Health has halted its clinical trial of the anti-malaria drug hydroxychloroquine after finding that the treatment provides no benefit to COVID-19 patients.

from Health and Science https://ift.tt/2Bn3Xv2
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH